Health tech deals
Health Tech World explores the latest investment developments in the world of healthcare. US$8m to advance AI-powered early cancer detection C the Signs, the creator of an AI-based platform to identify patients at risk of cancer at the earliest and most curable stage, has received US$8m in funding from Khosla Ventures. The new capital will [...]
A new biotech company focused on developing novel treatments for obesity has been backed by US$410m in investment. According to the company, it will advance a portfolio of next-generation oral and injectable treatments plans to advance through a mix of monotherapy and combination programmes. These include a Phase 2-ready, once-weekly oral GLP-1 receptor agonist; a [...]
Digital healthcare provider for obesity treatment, Yazen, has acquired the Danish company Medstart, enabling Yazen's expansion into Denmark. Following Yazen’s recent completion of a €19.5m investment round, the acquisition of Medstart enables Yazen to further develop its offerings and expand into new markets. Initially, Medstart will continue to operate under its existing brand, then in [...]
Gene therapy company, Concinnity Genetics, has raised £3m to establish RNA-based control systems for precise control of gene therapies in oversubscribed round. Concinnity is designing novel control mechanisms using its AI platform and synthetic biology expertise. The RNA-based systems enable the precise control of gene therapies even after dosing, conveying the ability to respond to [...]
A wellness industry tech platform, bsport, has raised €30m to fund its global expansion and accelerate its artificial intelligence (AI) and services. bsport’s expansion will include the UK, Europe, North America and APAC, and the company has confirmed it intends to triple its workforce by 2026. bsport was founded in 2018, providing wellness studios with [...]
A patented drug delivery platform treating cancer ‘locally’ – BioSapien – has raised $5.5m that will go towards funding clinical trials in patients of the company's flagship product, MediChip, a 3D-printed, slow-release drug delivery platform that can be attached to any tissue. The clinical trials will take place in the UAE - with patient enrolments [...]
Ulster University spinout Dia Beta Labs has raised £1.2m to accelerate the development of a breakthrough treatment for obesity and type 2 diabetes. With more than 4 million people in the UK living with diabetes and £10 bn per year spent by the NHS on related care, there is a pressing need for more effective [...]
Nordic biotech company Pila Pharma saw stocks soar this year due its asset XEN-D0501 - a formulated as an oral tablet currently undergoing clinical phase II testing as a treatment for obesity in patients with type 2 diabetes. The company was founded by Dorte X. Gram, a former Novo Nordisk researcher who during her time [...]
The healthcare technology sector has experienced remarkable growth in the past two-year period, with the total global exit value among healthcare technology companies doubling from $24.7bn in 2023 to $46 bn in 2024, according to new data released by Nina Capital today. The data also reveals the number of exits worth more than $1 bn [...]
New research has revealed that the healthcare sector recorded a 30 per cent decline in funding rounds between Q1 and Q3 of 2024. Between Q1 and Q3 of 2024, the total number of healthcare funding rounds reached 6,551 marking a 30 per cent decrease from the same period last year. Overall, the software sector recorded [...]
